|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2010-12-21
|
|
pubmed:abstractText |
rifampicin lowers nevirapine plasma concentrations by inducing cytochrome P450. However, few data are available on this interaction during the lead-in period of nevirapine treatment.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1460-2091
|
|
pubmed:author |
pubmed-author:BackDavidD,
pubmed-author:BoffitoMartaM,
pubmed-author:Byakika-KibwikaPaulineP,
pubmed-author:CoakleyPeterP,
pubmed-author:ColebundersRobertR,
pubmed-author:KalemeeraFrancisF,
pubmed-author:KhooSayeS,
pubmed-author:LamordeMohammedM,
pubmed-author:MerryConceptaC,
pubmed-author:NamakulaRhodaR,
pubmed-author:Okaba-KayomVioletV,
pubmed-author:RyanMairinM
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
66
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
180-3
|
|
pubmed:meshHeading |
pubmed-meshheading:21047828-Adult,
pubmed-meshheading:21047828-Anti-Bacterial Agents,
pubmed-meshheading:21047828-Anti-HIV Agents,
pubmed-meshheading:21047828-Drug Interactions,
pubmed-meshheading:21047828-Female,
pubmed-meshheading:21047828-HIV Infections,
pubmed-meshheading:21047828-HIV-1,
pubmed-meshheading:21047828-Humans,
pubmed-meshheading:21047828-Male,
pubmed-meshheading:21047828-Nevirapine,
pubmed-meshheading:21047828-Plasma,
pubmed-meshheading:21047828-Rifampin,
pubmed-meshheading:21047828-Time Factors,
pubmed-meshheading:21047828-Tuberculosis,
pubmed-meshheading:21047828-Uganda
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Nevirapine pharmacokinetics when initiated at 200 mg or 400 mg daily in HIV-1 and tuberculosis co-infected Ugandan adults on rifampicin.
|
|
pubmed:affiliation |
Research Department, Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda. mlamorde@idi.co.ug
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
